James P. Boylan's most recent trade in Compass Therapeutics Inc was a trade of 40,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Compass Therapeutics Inc | James P. Boylan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Immunome Inc | James P. Boylan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,333 | 11,333 | - | - | Stock option (right to buy) | |
Compass Therapeutics Inc | James P. Boylan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |